Michael Offin

Also affiliated with Cornell University, Weill Cornell Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.296Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library

Genome Medicine(2022)10.1186/s13073-022-01129-4

Top 55%

0.296DataRank

Top 55%5 citations

Jennifer L. Sauter, Sam E. Tischfield, Jacklynn V. Egger, Shweta S. Chavan, Nisargbhai Shah +14 more

Papers

Driven by 58 papers — median percentile 22. Top paper: “MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions”.

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3321

N/A

1.9DataRank · unranked

48 citations

Adam J. Schoenfeld, Evan Siau, Yue Christine Lu, Huichun Tai, Ken Suzawa +17 more

Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy

Cancer Research(2021)10.1158/0008-5472.can-21-2964

N/A

1.7DataRank · unranked

51 citations

Hirokazu Taniguchi, Yuan Hao, Andrew Chow, Yingqian A. Zhan, Shweta S. Chavan +21 more

Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers

Investigational New Drugs(2021)10.1007/s10637-020-01035-9

N/A

1.2DataRank · unranked

32 citations

D. Liu, Michael Offin, Cecilia Lezcano, Jean Torrisi, Sheldon L. Brownstein +13 more

Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer

Cancer Cell(2021)10.1016/j.ccell.2021.09.008

N/A

0.912DataRank · unranked

437 citations

Àlvaro Quintanal-Villalonga, Vianne R. Gao, Yubin Xie, Viola Allaj, Ojasvi Chaudhary +29 more

COVID-19 in patients with lung cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.06.007

N/A

0.840DataRank · unranked

270 citations

Hira Rizvi, Isabel R. Preeshagul, Jacklynn V. Egger, David Hoyos, Chai Bandlamudi +26 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0.792DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Chromothripsis-Mediated Small Cell Lung Carcinoma

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0286

N/A

0.584DataRank · unranked

48 citations

Sam E. Tischfield, Christopher A. Febres‐Aldana, Jake June-Koo Lee, Jason C. Chang, Benjamin Herzberg +37 more

The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study

The Lancet Digital Health(2021)10.1016/s2589-7500(21)00104-7

N/A

0.564DataRank · unranked

42 citations

Axel Martin, Jacklynn V. Egger, Hira Rizvi, Michael Offin, Andreas Rimner +7 more

Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3981

N/A

0.472DataRank · unranked

12 citations

Soo‐Ryum Yang, Jessica J. Tao, Antoine Desîlets, Eli L. Diamond, Clare Wilhelm +18 more

Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma

Modern Pathology(2024)10.1016/j.modpat.2023.100420

N/A

0.442DataRank · unranked

18 citations

Jason C. Chang, Achim A. Jungbluth, Prasad S. Adusumilli, Francis M. Bodd, Denise Frosina +13 more

Signatures of plasticity and immunosuppression in a single-cell atlas of human small cell lung cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8509

N/A

0.439DataRank · unranked

5 citations

Àlvaro Quintanal-Villalonga, Vianne R. Gao, Viola Allaj, Ignas Masilionis, Ojasvi Chaudhary +14 more

Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.2526

N/A

0.406DataRank · unranked

14 citations

Xiao Wang, Leonid Roshkovan, Connor B. Grady, John T. Miura, Michelle S. Ginsberg +15 more

Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3025

N/A

0.345DataRank · unranked

9 citations

Vicky Makker, Darren J. Buonocore, Ronglai Shen, Rona Yaeger, Michelle S. Ginsberg +15 more

Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21098

N/A

0.330DataRank · unranked

8 citations

Debra A. Goldman, Sabrina T. Lin, Darren J. Buonocore, Jianjiong Gao, Jason C. Chang +15 more

Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library

Genome Medicine(2022)10.1186/s13073-022-01129-4

Top 55%

0.296DataRank

Top 55%5 citations

Jennifer L. Sauter, Sam E. Tischfield, Jacklynn V. Egger, Shweta S. Chavan, Nisargbhai Shah +14 more

A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100440

N/A

0.292DataRank · unranked

6 citations

Prasad S. Adusumilli, Michael Offin, Stephen B. Solomon, Etay Ziv, Sara A. Hayes +22 more

Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.11.010

N/A

0.269DataRank · unranked

5 citations

Rohit Thummalapalli, Christopher A. Febres‐Aldana, Daniel M. Muldoon, Christina J. Falcon, Amanda Pupo +18 more

Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9067

N/A

0.269DataRank · unranked

5 citations

Angela B. Hui, Jacob J. Chabon, Everett J. Moding, Emily S. Lebow, José de Arimateia Batista Araújo-Filho +15 more

The Impact of Durvalumab on Local-Regional Control in Stage III NSCLCs Treated With Chemoradiation and on KEAP1-NFE2L2-Mutant Tumors

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.04.019

N/A

0DataRank · unranked

16 citations

Michael Offin, Annemarie F. Shepherd, Charles B. Simone, Daphna Y. Gelblum, Abraham J. Wu +6 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9009

N/A

0DataRank · unranked

19 citations

Emily S. Lebow, Yonina R. Murciano‐Goroff, Gowtham Jayakumaran, Ronglai Shen, A. Rose Brannon +15 more

Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations

Journal of Molecular Diagnostics(2022)10.1016/j.jmoldx.2022.03.006

N/A

0DataRank · unranked

17 citations

Jada Barbee, Soo‐Ryum Yang, Jason C. Chang, Priscilla Liang, Kerry Mullaney +9 more

Multimodality Therapy in Patients With Primary Pericardial Mesothelioma

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.08.017

N/A

0DataRank · unranked

16 citations

Dilanka L De Silva, Jennifer L. Sauter, Jacklynn V. Egger, Ellen Yorke, Prasad S. Adusumilli +4 more

Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer

Translational Lung Cancer Research(2022)10.21037/tlcr-22-164

N/A

0DataRank · unranked

7 citations

Michael Offin, Jessica Flynn, Zhigang Zhang, Emily S. Lebow, Khaled Aziz +9 more

Dual NF2-YAP/TAZ immunohistochemistry is a reliable marker for the detection of NF2 alterations in diffuse pleural mesothelioma

Research Square(2022)10.21203/rs.3.rs-1720495/v1

N/A

0DataRank · unranked

0 citations

Soo‐Ryum Yang, Ying‐Bei Chen, Prasad S. Adusumilli, Ann Bialik, Francis M. Bodd +9 more

Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patients with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab

JAMA Network Open(2023)10.1001/jamanetworkopen.2022.49591

N/A

0DataRank · unranked

23 citations

Annemarie F. Shepherd, Jordan Eichholz, Michael Offin, Daphna Y. Gelblum, Abraham J. Wu +9 more

Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma

Radiotherapy and Oncology(2023)10.1016/j.radonc.2023.110057

N/A

0DataRank · unranked

10 citations

Michael Offin, Charles B. Simone, Zhigang Zhang, Annemarie F. Shepherd, Abraham J. Wu +10 more

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

Radiotherapy and Oncology(2023)10.1016/j.radonc.2023.109983

N/A

0DataRank · unranked

9 citations

Kelly Fitzgerald, Aditya Apte, Jung Hun Oh, Aditi Iyer, Otasowie Odiase +12 more

Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma

Modern Pathology(2023)10.1016/j.modpat.2022.100030

N/A

0DataRank · unranked

13 citations

Soo‐Ryum Yang, Ying‐Bei Chen, Prasad S. Adusumilli, Ann Bialik, Francis M. Bodd +9 more

Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting

Cancer Cytopathology(2023)10.1002/cncy.22705

N/A

0DataRank · unranked

5 citations

Abeer M. Salama, Marina K. Baine, Francis M. Bodd, Michael Offin, Natasha Rekhtman +5 more

The past, present, and future of targeted therapeutic approaches in patients with diffuse pleural mesotheliomas

Journal of Cancer Metastasis and Treatment(2023)10.20517/2394-4722.2022.140

N/A

0DataRank · unranked

1 citations

Bailey G. Fitzgerald, Marjorie G. Zauderer, Deborah B. Doroshow, Michael Offin

Data from Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy

(2023)10.1158/0008-5472.c.6513732.v1

N/A

0DataRank · unranked

0 citations

Hirokazu Taniguchi, Yuan Hao, Andrew Chow, Yingqian A. Zhan, Shweta S. Chavan +21 more

Data from Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes

(2023)10.1158/1078-0432.c.6530487.v1

N/A

0DataRank · unranked

0 citations

Michael Offin, Christina J. Falcon, David N. Brown, Brian Houck‐Loomis, Fanli Meng +21 more

Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer

JCO Precision Oncology(2024)10.1200/po.24.00216

N/A

0DataRank · unranked

9 citations

Angela BY Hui, José de Arimateia Batista Araújo-Filho, Emily G. Hamilton, Jacob J. Chabon, Everett J. Moding +20 more

Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0085

N/A

0DataRank · unranked

7 citations

Gowtham Jayakumaran, Jamal Benhamida, Christopher A. Febres Aldana, Rachel Fanaroff, Jason C. Chang +7 more

Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors

Annals of Surgical Oncology(2024)10.1245/s10434-024-16004-2

N/A

0DataRank · unranked

6 citations

Nicole Aguirre, Soo Ryum Yang, Jennifer L. Sauter, Georgios Karagkounis, Mostafa Mohamed +9 more

Safety and efficacy of percutaneous cryoablation for primary and metastatic pleural based tumors

European Journal of Radiology(2024)10.1016/j.ejrad.2024.111465

N/A

0DataRank · unranked

1 citations

Elena N. Petre, Michael Offin, Marjorie G. Zauderer, Ken Zhao, Vlasios S. Sotirchos +3 more

Correlation of Histologic Features with Gene Alterations in Pleural Mesothelioma

Modern Pathology(2025)10.1016/j.modpat.2025.100706

N/A

0DataRank · unranked

6 citations

Soo‐Ryum Yang, Kay See Tan, Prasad S. Adusumilli, Francis M. Bodd, Anita S. Bowman +10 more

Leveraging RNA from DNA Extraction Lysate to Rescue “Insufficient” Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor Specimens

Journal of Molecular Diagnostics(2025)10.1016/j.jmoldx.2025.04.005

N/A

0DataRank · unranked

0 citations

Sara DiNapoli, Kerry Mullaney, Alison M. Urvalek, Minji K. Uh, Purvil Sukhadia +14 more

ASO Visual Abstract: Clinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma

Annals of Surgical Oncology(2025)10.1245/s10434-025-18200-0

Top 100%

0DataRank

Top 100%0 citations

Fady Baky, Judy Sarungbam, Joel Sheinfeld, Victor E. Reuter, Andrea Cercek +9 more

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0215

N/A

0DataRank · unranked

293 citations

Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai +44 more

ALK Inhibitor Response in Novel ZFPM2::ALK and TRIM24::ALK Fusion-Positive Lung Cancers: Case Report

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100934

N/A

0DataRank · unranked

0 citations

Mohamed A. Yakoub, Michael Offin, Juliana Eng, Alexander Drilon, Soo-Ryum Yang +1 more

Characterization of on-target adverse events caused by TRK inhibitor therapy

Annals of Oncology(2020)10.1016/j.annonc.2020.05.006

N/A

0DataRank · unranked

86 citations

James Flory, Andrew Lin, Michael Offin, Christina J. Falcon, Yonina R. Murciano‐Goroff +16 more

Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab

Radiotherapy and Oncology(2020)10.1016/j.radonc.2020.04.047

N/A

0DataRank · unranked

56 citations

Narek Shaverdian, Andreas Rimner, Stephanie Lobaugh, Annemarie F. Shepherd, Charles B. Simone +10 more

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab

Cancer Medicine(2020)10.1002/cam4.3113

N/A

0DataRank · unranked

64 citations

Maria Thor, Annemarie F. Shepherd, Michael Offin, Andrew Jackson, Abraham J. Wu +9 more

Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors

Annals of Oncology(2020)10.1016/j.annonc.2020.09.016

N/A

0DataRank · unranked

52 citations

Jason Beattie, Maria Thor, Michael Offin, Annemarie F. Shepherd, Daphna Y. Gelblum +7 more

Clinical and Dosimetric Predictors of Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation Therapy

Practical Radiation Oncology(2020)10.1016/j.prro.2020.09.014

N/A

0DataRank · unranked

22 citations

Michelle Iocolano, Jonathan E. Leeman, Brandon S. Imber, Aaron T. Wild, Michael Offin +11 more

Allele-Specific Role of ERBB2 in the Oncogenic Function of EGFR L861Q in EGFR-Mutant Lung Cancers

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.09.019

N/A

0DataRank · unranked

19 citations

Michael Offin, Daisuke Kubota, Helena A. Yu, Clare Wilhelm, Shinichi Toyooka +4 more

Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.02.408476

N/A

0DataRank · unranked

24 citations

Hirozaku Taniguchi, Yingqian A. Zhan, Maysun Hasan, Fanli Meng, Fathema Uddin +23 more

Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1863

N/A

0DataRank · unranked

181 citations

Hirokazu Taniguchi, Yingqian A. Zhan, Maysun Hasan, Shweta S. Chavan, Fanli Meng +31 more

Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01186-z

N/A

0DataRank · unranked

93 citations

Hirokazu Taniguchi, Yingqian A. Zhan, Maysun Hasan, Shweta S. Chavan, Fanli Meng +25 more

Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0423

N/A

0DataRank · unranked

105 citations

Michael Offin, Christina J. Falcon, David N. Brown, Brian Houck‐Loomis, Fanli Meng +21 more

Molecular Characterization of Peritoneal Mesotheliomas

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.09.012

N/A

0DataRank · unranked

51 citations

Soo‐Ryum Yang, Jacklynn V. Egger, Gowtham Jayakumaran, Rowanne S Spencer, Jessica Lopardo +8 more

Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.03.023

N/A

0DataRank · unranked

40 citations

Jason C. Chang, Charles Leduc, Kay See Tan, Snjezana Doğan, Ryma Benayed +8 more

CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials

Lung Cancer(2021)10.1016/j.lungcan.2021.05.004

N/A

0DataRank · unranked

33 citations

David Restle, Hue Tu Quach, Jasmeen Saini, Rebecca Y. Bellis, Michael Offin +3 more

Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.03.013

N/A

0DataRank · unranked

32 citations

Marissa S. Mattar, Allan J.W. Lui, Michael Offin, Christopher Kurzatkowski, Lukas Delasos +9 more

Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100197

N/A

0DataRank · unranked

25 citations

Michael Offin, Annemarie F. Shepherd, Matthew D. Hellmann, Daniel R. Gomez, Jamie E. Chaft +2 more

Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab

Radiotherapy and Oncology(2021)10.1016/j.radonc.2021.12.016

N/A

0DataRank · unranked

21 citations

Annemarie F. Shepherd, Isabel R. Preeshagul, Michael Offin, Daphna Y. Gelblum, Abraham J. Wu +9 more

Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100209

N/A

0DataRank · unranked

20 citations

Anthony F. Yu, Michelle Iocolano, Jonathan E. Leeman, Aaron T. Wild, Brandon S. Imber +13 more

Michael Offin

Indexed papers

Top data-sharing exemplar

Papers